Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $23.0000 (-4.56%) ($21.0000 - $23.8900) on Fri. Oct. 20, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 12.48% (three month average) | RSI | 20 | Latest Price | $23.0000(-4.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -12% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWG(8%) SKYY(8%) TBT(8%) ARKK(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -6.24% in a week (0% probabilities). TLT(-8%) GLD(-8%) GDX(-7%) SLV(-6%) SIL(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -6.24% (StdDev 12.48%) | Hourly BBV | 0 () | Intraday Trend | 2.7% | | | |
|
Resistance Level | $26.08 | 5 Day Moving Average | $24.04(-4.33%) | 10 Day Moving Average | $24.81(-7.3%) | 20 Day Moving Average | $26.08(-11.81%) | To recent high | -33.3% | To recent low | 148.6% | Market Cap | $453m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |